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CAS CLINIQUE / CASE REPORT

Médecine orale / Oral Medicine

EARLY DIAGNOSIS OF ORAL CAVITY CARCINOMAS: THE
BEST PROGNOSTIC FACTOR
Edgard Nehmé*| Chadi Farah**| Jeanine Hoyek-Gebeily***| Hachimia Fahs****|
Alexandre Saber*****| Antoine Melkane******
Abstract
Oral mucosa neoplasms are most often pre-malignant lesions that evolved in squamous cell carcinoma (90% of cancers of the oral cavity).
Tobacco and alcohol are the two most incriminated etiological factors. Other etiologies have also been mentioned, in particular the oncogenicity of certain viruses like the human papillomavirus (HPV). However, other types of cancer may occur mainly in young adults whose
starting point is generally a salivary gland (10% of cancers of the oral cavity). From two clinical cases, squamous cell carcinoma and mucoepidermoid carcinoma, we describe the etiopathogenesis and the clinical characteristics as well as the histopathological particularities,
diagnosis and prognosis of each of these entities. We also developped the interest of an early detection of the lesions that will provide the
patient a better prognosis even though the therapeutic strategy is established in the best conditions.
Keywords: Oral carcinoma – diagnosis –pre-malignant lesion – squamous cell carcinoma.
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DIAGNOSTIC PRÉCOCE DES CARCINOMES DE LA CAVITÉ ORALE:
LE MEILLEUR FACTEUR DE PRONOSTIC
Résumé
Les cancers de la muqueuse buccale sont le plus souvent des lésions pré-malignes ayant évoluées en carcinome épidermoide (90% des
cancers de la cavité buccale). Tabac et alcool sont les deux facteurs étiologiques les plus incriminés. D’autres étiologies ont aussi été
évoquées notamment l’oncogénicité de certains virus comme le papillomavirus humain. Toutefois d’autres types de cancers peuvent se
manifester, surtout chez les jeunes adultes, dont le point de départ est une glande salivaire (10% des cancers de la cavité buccale). A partir
de deux cas cliniques de carcinome épidermoide et de carcinome muco-épidermoide, nous décrivons l’étiopathogénie et les caractères
cliniques ainsi que les particularités histopathologiques, diagnostiques et pronostiques de chacune de ces entités. Est aussi développé
l’intérêt du repérage précoce des lésions qui fera bénéficier le patient d’un meilleur pronostic encore que la stratégie thérapeutique soit
établie dans les meilleures conditions.
Mots-clés: cancer oral – lésions pré-malignes – carcinome épidermoïde – diagnostic.
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Introduction
Oral cavity neoplasms can have
similar clinical manifestations, including pain, swelling, asymptomatic
white or red lesion and many others
[1]. Early diagnosis may be possible
during examination of the oral cavity
or discovered during dental work-up
for another complaint. Studies showed
that 90% of oral cavity neoplasms
consist of squamous cell carcinomas
(SCC). The remaining 10% of malignancies consist of carcinomas of minor
salivary glands (3-5%), sarcomas of the
soft tissues and the bone, malignant
odontogenic tumors, malignant melanomas, non-Hodgkin lymphomas, and
metastases from primary tumors located elsewhere in the body [2].
SCC is an epithelial tumor
that arises from the oral mucosa.
Traditional risk factors include chronic
tobacco exposure, alcohol consumption and Betel quid chewing. Poor oral
hygiene resulting in chronic periodontal disease as well as repetitive
dental microtraumas have been also
implicated. Many studies have tried
to identify a causative role of Human
Papillomavirus (HPV) infection in oral
cancers, but no conclusive data could
be drawn to this date. When SCC is
identified, it is considered as a primary
lesion of the oral mucosa and investigations should be done to rule out
loco-regional spread [3].
The most common types of minor
salivary gland carcinomas include
mucoepidermoid carcinoma (MEC)
and adenoid cystic carcinoma [4].
MEC is derived from ductal epithelial cells of the salivary gland and
contains mucus-producing, epidermoid and intermediate cells. Although
usually occurring in the parotid gland
in the head and neck region, it is often
found in the palate when a minor
salivary gland is affected [5]. The differential diagnosis of MEC should be
considered in the case of a painless,
slow-growing, pale, bluish-purple
lump, especially in the palate [6].
Several studies have tried to identify prognostic factors of minor salivary
gland MEC and palatal SCC. These

Fig. 1: A 2x1 cm violaceous indurated mass on
the right side of the hard palate (black arrow).

include age, tumor size, histopathological grade, clinical stage, perineural
and vascular involvement, and lymph
node or distant metastases [7]
In this paper, we present two cases
of oral cavity lesions with the same
location and clinical presentation
but different histopathological types.
Early diagnosis resulted in complete
minimally-invasive resection of the
lesions with no need for extensive
reconstruction nor any adjuvant therapy. Consequently, the two cases had
excellent oncologic and functional
outcomes.
Case 1
A 45-year-old female presented to
our department with a 6-month history
of an isolated painful lesion of the hard
palate, which was slowly increasing in
size. The patient’s past medical history
was unremarkable. Her social history
was significant for chronic tobacco
smoking (30 packs-years), but no alcohol exposure.
On physical exam, the lesion was
located at the junction of the hard and
soft palate facing the right molars. It
was erythematous, indurated on palpation and measured 2 x 1 cm (Fig. 1).
She showed no improvement after
a one-week course of antibiotics and a
fine needle aspiration cytology (FNAC)
was inconclusive. Contrast-enhanced

CT scan showed no underlying bony
invasion (Fig. 2).
An excisional biopsy under general anesthesia was performed and
frozen section was in favor of a SCC.
Subsequently, a wider resection was
performed in safe margins (Fig. 3).
Final pathology revealed a pT1 lowgrade MEC.
The post-operative course was
uneventful. The patient was kept on a
liquid diet for a couple of days, then
resumed a soft diet. Regular 3-month
follow-up visits were recommended for
the first year. Her latest follow-up at 18
months showed no evidence of disease
recurrence.
Case 2
A 71-year old male, chronic tobacco
smoker (35 packs-years) and daily
alcohol consumer, presented with a
5-month history of a painful lesion
located at the junction of the left
anterior tonsillar pillar and the intermaxillary commissure. The clinical
examination revealed a 2x2 cm round,
homogenous, erythematous lesion
with elevated borders (Fig. 4).
A biopsy was carried out with
pathology results of poorly-differentiated SCC. A dedicated contrastenhanced CT scan showed no enlarged
lymph nodes (Fig. 5).
The lesion was resected under
general anesthesia with a circumferen-
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Fig. 2: CT scan showing no underlying bony invasion.

Fig. 3: A. Wide margin-surgical excision.
B. Final post-operative result.

tial 1 cm safety margin, preserving deeply the medial pterygoid muscle (Fig.
6). A buccinator flap, pedicled on the
buccal branch of the internal maxillary
artery, along with the Bichat’s fat pad
was used to close the defect (Fig. 7).
Final pathology revealed a pT1
poorly
differentiated
infiltrating
SCC with clear margins and only
one peri-neural invasion finding.

Subsequently no adjuvant therapy was
recommended.
The post-operative course was
uneventful. The patient was kept with
no oral intake for 4 days and was fed
through a naso-gastric tube. He resumed a liquid diet on post-operative
day 5, then a soft diet for a period of 10
days. The operative site was very clean
with the buccinator flap looking very

healthy. The 2-week follow-up showed
a very smooth healing of the reconstructed soft palate, with no significant
retractions of the inner cheek. Regular
3-month follow-up visits were recommended for the first year. The contrastenhanced CT scan at 6 months and his
latest follow-up at 18 months showed
no evidence of disease recurrence.
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Fig. 4: A 2x2 cm erythematous and
indurated lesion (black arrow).

Discussion
Oral cavity malignancies often
have the same clinical presentation
regardless of their histopathologic
type. They can be symptomatic and
manifests as a painful mass or asymptomatic and incidentally diagnosed on
routine oral cavity examination. They
can present as exophytic or ulcerative
lesions [1]. Sometimes precancerous
lesions are identified and these present either as white or red lesions,
namely leukoplakias or erythroplakias,
or as reticulated, lichenoid, lesions.
The most frequent histopathologic
type of oral cavity malignancies is by
far SCC of the mucosal lining followed
by Adenoid cystic carcinoma and MEC
of minor salivary glands [2, 4].
SCC represent 90% of oral cavity
neoplasms. Most common sites
include the ventral or dorsal aspects
of the tongue, the floor of mouth and
the oral vestibule. Less common sites
include the palate and the retromolar
trigone. It occurs in patients over a
wide age range, but the majority present in the 6th through 8th decades,
with a mean age of 60-65 years. They
are unusual in patients younger than
20 years, although several cases
have been described. Males are more

Fig. 5: Preoperative scan showed no
radiographic abnormalities either at the
primary site or in the neck.

frequently affected than females [3, 8].
The major risk factors include smoking,
alcohol consumption and Betel quid
chewing [1].
MEC of the oral cavity originates
in the ductal epithelium of the major
or minor salivary glands. In the minor
salivary glands, MEC most commonly
arises in the palate, followed by the
lower lip, but it can also be found in
the retromolar trigone, floor of the
mouth, buccal mucosa and tongue [9].
The peak age of occurrence of MEC is
the sixth decade of life. The majority of
the studies in the literature support a
female preponderance [10]; however,
some publications have also found
males to be more frequently affected
[11].
Prognostic factors of these 2 types
of tumors include tumor histologic
grade, neural invasion, extension to
soft tissue and tumor thickness, age
at diagnosis and gender, adequacy
of excision (microscopic residual
disease), lymph node metastasis and
extracapsular spread [7, 12].
These factors have shown a correlation with recurrence and survival
rates. Among these factors, tumor
stage appears to be the most important prognostic indicator [6, 10, 13, 14].
Advanced stage tumors have a worse

prognosis, while early stage tumors
have a better prognosis.
Local recurrence has been found
to have no negative effect on overall
survival; however, the need for further
disfiguring surgery may be needed.
The need for a complete excision with
adequate margins is crucial in order to
prevent local recurrence [11].
In other words, early detection of a
tumor in its early stage is the best prognostic factor. Disease stage at initial
presentation is a major determinant of
survival, and the choice of treatment
depends on the anatomical location
and clinical stage.
In this paper we present 2 cases
of oral cavity malignancies, a case of
MEC and a case of SCC, with the same
presentation. Minimally-invasive excision and reconstruction were the only
needed curative treatment ensuring
excellent oncologic outcome and functional results.
Unfortunately, most oral cavity
SCC are diagnosed in advanced stages
(stages III or IV) with a survival rate
at 5 years of less than 50% and a cure
rate of 30%. Untreated patients with
metastatic disease survived for about
6 months. Only one third of the oral
cavity SCCs are diagnosed in early
stages (stages I or II). Studies showed
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Fig. 6: Surgical defect after wide resection
of the lesion, peeled off the medial
pterygoid muscle (black arrow).

that these patients have a better prognosis with cure rates of more than
80% for stage I tumors and 65% for
stage II [15].
Tong et al. [1] found that a diagnostic delay longer than 2 months, T3 or
T4 tumor, neck metastasis, and stage
III or IV disease were independent
adverse factors for subsequent survival rate and locoregional recurrence
in patients with oral SCC. A delay in
diagnosis shorter than 2 months was
associated with a more favorable stage
at diagnosis and a higher 2-year survival rate [1].
One of the major reasons of delay
in diagnosing oral cancers was found
to be, in a case-control study in 2010,
administration of self-treatment provided by a pharmacy or use of over-thecounter products [16].
Moreover, when adequate early
treatment of oral cavity tumors is
applied, survival rates become more
favorable. Li et al. showed high 5- and
10-year survival rates in MEC of the
hard palate (78.7%) when lesions were
diagnosed early and surgical excision
was performed with adequate margins
[4].
The fact that most oral cavity cancer cases presented in the majority of
the studies with an advanced disease

Fig. 7: A. Buccinator flap donor site (black arrow). B. Final result of the
reconstructed site: Buccinator flap (black arrow) and Bichat’s fat pad
(white arrow).

stage reflect a need for general public
awareness of these diseases, their
risk factors, and the importance of
regular professional oral cavity examinations. Clinicians, especially
general dental practitioners and oral
surgeons, should be aware of the risk
of oral cavity cancers in heavy smokers, drinkers, and betel quid chewers,
and shouldn’t hesitate to biopsy any
suspicious lesion or unhealing ulcer
in order to rule-out malignancy. (1)
respectively. Multivariate analyses
showed that a diagnostic delay longer than 2 months (hazard ratio
[HR]=4.43; 95% confidence interval
[CI], 1.26-15.51; P=.02
Oral cavity carcinomas are typically treated by surgery, including
excision of the primary site and
neck dissection, depending on the
pathologic type. When diagnosed
early and when complete resection
can be obtained in safe margins, no
adjuvant treatment is usually required. Otherwise an adjuvant radiation
therapy or a chemoradiation therapy
might be indicated. When surgery is
not possible (irresectable tumor or
inoperable patient), the latter two
options could be indicated as exclusive therapies [4, 15].

In early diagnosed lesions, as in our
two cases, limited surgery and reconstruction were oncologically sufficient
and ensured an excellent quality of life.
More advanced cases usually require
disfiguring surgeries, more complex
reconstructions and adjuvant therapies, thus compromising functional
outcomes.

Conclusion
Oral cavity neoplasms can have
similar presentations depending on
their locations, SCC being the most
frequent malignant tumor followed by
MEC of minor salivary glands. Many prognostic factors have been identified and
disease-free survival rate remains the
main outcome of interest. Although the
management of these tumors improves
continuously, surgery is still considered
as the primary option. Early diagnosis
and prompt referral to a specialist will
offer the best chance of cure in most
patients avoiding disfiguring surgeries,
complex reconstructions and the need
for adjuvant therapies.
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